SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-24-013397
Filing Date
2024-02-13
Accepted
2024-02-13 17:00:16
Documents
1
Group Members
VIVO CAPITAL FUND VIII, L.P.VIVO CAPITAL SURPLUS FUND VIII, L.P.VIVO PANDA FUND, L.P.VIVO PANDA, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G ea193541-13ga1vivo8_bolt.htm SC 13G/A 113929
  Complete submission text file 0001213900-24-013397.txt   115684
Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Filed by) CIK: 0001618789 (see all company filings)

IRS No.: 471761992 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Subject) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92160 | Film No.: 24627540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)